{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T06:23:38Z","timestamp":1791354218096,"version":"4.3.1"},"reference-count":24,"publisher":"Informa UK Limited","issue":"5","license":[{"start":{"date-parts":[[2022,6,10]],"date-time":"2022-06-10T00:00:00Z","timestamp":1654819200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"funding"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Human Vaccines & Immunotherapeutics"],"published-print":{"date-parts":[[2022,11,30]]},"DOI":"10.1080\/21645515.2022.2081024","type":"journal-article","created":{"date-parts":[[2022,6,10]],"date-time":"2022-06-10T21:02:57Z","timestamp":1654894977000},"update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":19,"title":["Safety and clinical efficacy of human rabies immunoglobulin in post exposure prophylaxis for category III animal exposures"],"prefix":"10.1080","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0583-0826","authenticated-orcid":false,"given":"Ravish S.","family":"Haradanhalli","sequence":"first","affiliation":[{"name":"Department of Community Medicine, Kempegowda Institute of Medical Sciences, Bangalore, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nidhi","family":"Fotedar","sequence":"additional","affiliation":[{"name":"Department of Community Medicine, Kempegowda Institute of Medical Sciences, Bangalore, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6348-997X","authenticated-orcid":false,"given":"Nitu","family":"Kumari","sequence":"additional","affiliation":[{"name":"Department of Community Medicine, Bangalore Medical College & Research Institute, Bangalore, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D. H. Ashwath","family":"Narayana","sequence":"additional","affiliation":[{"name":"Department of Community Medicine, Kempegowda Institute of Medical Sciences, Bangalore, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2022,6,10]]},"reference":[{"key":"e_1_3_3_3_1","doi-asserted-by":"publisher","DOI":"10.3390\/tropicalmed2020005"},{"key":"e_1_3_3_4_1","unstructured":"World Health Organization. WHO South East Asia Region: Strategic framework for elimination of human rabies transmitted by dogs in the South\u2013East Asia region. Regional Office for South East Asia World Health Organization; 2012."},{"key":"e_1_3_3_5_1","doi-asserted-by":"publisher","DOI":"10.1590\/S0042-96862005000500012"},{"key":"e_1_3_3_6_1","first-page":"201","article-title":"Weekly epidemiological record. Rabies Vaccines: WHO position paper No. 16","volume":"93","author":"World Health Organization","year":"2018","unstructured":"World Health Organization. Weekly epidemiological record. Rabies Vaccines: WHO position paper No. 16. Wkly Epidemiol Rec 2018;93:201\u20135.","journal-title":"Wkly Epidemiol Rec"},{"key":"e_1_3_3_7_1","doi-asserted-by":"publisher","DOI":"10.4103\/ijph.IJPH_367_19"},{"key":"e_1_3_3_8_1","first-page":"618","volume-title":"National rabies control programme. National Centre for Diseases Control","author":"National Guidelines for Rabies Prophylaxis","year":"2019","unstructured":"National Guidelines for Rabies Prophylaxis. National rabies control programme. National Centre for Diseases Control. New Delhi (India): Ministry of Health and Family Welfare; 2019. p. 618."},{"key":"e_1_3_3_9_1","volume-title":"The global strategic plan to end human deaths from dog mediated rabies by 2030","author":"Zero by 30","year":"2018","unstructured":"Zero by 30. The global strategic plan to end human deaths from dog mediated rabies by 2030. Geneva: Food and Agriculture Organization of the United Nations, World Organisation for Animal Health, World Health Organization and Global Alliance for Rabies Control; 2018."},{"key":"e_1_3_3_10_1","first-page":"773","article-title":"Laboratory data supporting the clinical trial of anti-rabies serum in persons bitten by a rabid wolf","volume":"13","author":"Habel K","year":"1955","unstructured":"Habel K, Koprowski H. Laboratory data supporting the clinical trial of anti-rabies serum in persons bitten by a rabid wolf. Bull World Health Organ. 1955;13:773\u201379.","journal-title":"Bull World Health Organ"},{"key":"e_1_3_3_11_1","doi-asserted-by":"publisher","DOI":"10.15761\/GVI.1000116"},{"key":"e_1_3_3_12_1","doi-asserted-by":"publisher","DOI":"10.47203\/IJCH.2018.v30i03.004"},{"key":"e_1_3_3_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.actatropica.2020.105629"},{"key":"e_1_3_3_14_1","doi-asserted-by":"publisher","DOI":"10.2307\/4585257"},{"issue":"4","key":"e_1_3_3_15_1","first-page":"593","article-title":"Rabies neutralizing antibody response to different schedules of serum and vaccine inoculations in non-exposed persons","volume":"14","author":"Atanasiu MB","year":"1956","unstructured":"Atanasiu MB, Baltazard M, Fox JP, Habel K, Kaplan MM, Kaplan MM, Kissling RE, Komarov A, Koprowski H, Lepine P, et al. Rabies neutralizing antibody response to different schedules of serum and vaccine inoculations in non-exposed persons. Bull World Health Organ. 1956;14(4):593\u2013611.","journal-title":"Bull World Health Organ"},{"key":"e_1_3_3_16_1","first-page":"747","article-title":"Field trials with rabies vaccine on persons bitten by rabid wolves","volume":"13","author":"Baltazard M","year":"1955","unstructured":"Baltazard M, Bahmanyar M. Field trials with rabies vaccine on persons bitten by rabid wolves. Bull World Health Organ. 1955;13:747\u201372.","journal-title":"Bull World Health Organ"},{"key":"e_1_3_3_18_1","first-page":"477","article-title":"Studies on the local treatment of rabies-infected wounds","volume":"28","author":"Dean DJ","year":"1963","unstructured":"Dean DJ, Baer GM, Thompson WR. Studies on the local treatment of rabies-infected wounds. Bull World Health Organ. 1963;28:477\u201386.","journal-title":"Bull World Health Organ"},{"key":"e_1_3_3_19_1","first-page":"1111","article-title":"Human antirabies gamma globulin","volume":"20","author":"Hosty TS","year":"1959","unstructured":"Hosty TS, Kissling RE, Schaeffer M, Wallace GA, Dibble EH. Human antirabies gamma globulin. Bull World Health Organ. 1959;20:1111\u201319.","journal-title":"Bull World Health Organ"},{"key":"e_1_3_3_20_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.102.5.1314"},{"key":"e_1_3_3_21_1","first-page":"303","article-title":"Rabies immune globulin of human origin: preparation and dosage determination in non-exposed volunteer subjects","volume":"45","author":"Cabasso VJ","year":"1971","unstructured":"Cabasso VJ, Loofbourow JC, Roby RE, Anuskiewicz W. Rabies immune globulin of human origin: preparation and dosage determination in non-exposed volunteer subjects. Bull World Health Organ. 1971;45:303\u201315.","journal-title":"Bull World Health Organ"},{"key":"e_1_3_3_22_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa779"},{"key":"e_1_3_3_23_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cix791"},{"key":"e_1_3_3_24_1","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2019.1656967"},{"key":"e_1_3_3_25_1","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2020.1854000"},{"key":"e_1_3_3_26_1","doi-asserted-by":"publisher","DOI":"10.24321\/0019.5138.202012"},{"key":"e_1_3_3_27_1","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2021.2013079"}],"container-title":["Human Vaccines & Immunotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/21645515.2022.2081024","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,5]],"date-time":"2024-02-05T21:07:39Z","timestamp":1707167259000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/21645515.2022.2081024"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,10]]},"references-count":24,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,11,30]]}},"alternative-id":["10.1080\/21645515.2022.2081024"],"URL":"https:\/\/doi.org\/10.1080\/21645515.2022.2081024","relation":{},"ISSN":["2164-5515","2164-554X"],"issn-type":[{"value":"2164-5515","type":"print"},{"value":"2164-554X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,10]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=khvi20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=khvi20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2022-01-31","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-05-19","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-06-10","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"2081024"}}